Quarterly report pursuant to Section 13 or 15(d)

STOCK WARRANTS AND STOCK OPTIONS (Details Narrative)

v3.21.1
STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Aug. 08, 2019
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Oct. 24, 2019
Number of warrants outstanding   550,000      
Exercise price of warrants   $ 3.00      
Share-based compensation expense   $ 18,690 $ 41,302 $ 39,450  
Expected lives   2 years      
Unrecognized compensation expense   $ 564,000      
Non Employee Stock Warrants [Member]          
Number of warrants outstanding   957,379   584,317  
Stock option granted   550,000   916,579  
Fair value of detached free-standing stock warrants granted   $ 619,381   $ 0  
2019 Equity Incentive Plans [Member]          
Stock option granted   2,521,921   2,521,921  
Common stock authorized shares         3,848,467
Stock option vested shares   1,376,118   1,202,724  
Stock option issued   $ 1,326,546   $ 1,326,546  
Stock option non-vested shares   1,145,803   1,319,197  
8% Series A-1 Convertible Preferred Stock Investment agreement [Member] | First Capital Ventures "FCV" [Member]          
Number of warrants outstanding   144,317   144,317  
Exercise price of warrants $ 1.039375        
Convertible preferred stock shares sold 1,000,000        
Sale of stock price per share $ 1        
Common stock shares issuable upon exercise of warrants to SPV 144,317        
Executive Stock Options [Member]          
Number of warrants outstanding   1,146,325   981,771  
Executive Stock Options [Member] | Minimum [Member]          
Options exercisable per share   $ 0.2634      
Executive Stock Options [Member] | Maximum [Member]          
Options exercisable per share   $ 2.97